These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5105950)

  • 1. [Effect of heterologous antilymphocyte globulin in chronic lymphoid leukemia].
    Pfisterer H; Lani K; Demmler K; Thierfelder S; Fateh-Moghadam A; Land W; Brendel W; Stich W
    Dtsch Med Wochenschr; 1971 Sep; 96(37):1468 passim. PubMed ID: 5105950
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heterologous antilymphocyte globulin].
    Brendel W; Land W
    Dtsch Med Wochenschr; 1971 Nov; 96(47):1851. PubMed ID: 5166113
    [No Abstract]   [Full Text] [Related]  

  • 3. Allergic reactions to a horse globulin therapy and their prevention by induction of immunological tolerance.
    Ring J; Seifert J; Lob G; Hopf U; Land W; Brendel W
    Allergol Immunopathol (Madr); 1974; 2(2):93-8. PubMed ID: 4211785
    [No Abstract]   [Full Text] [Related]  

  • 4. [Side effects of therapy with antihuman lymphocyte globulin].
    Exadaktylos P; Rumler W; Oppermann J; Grävinghoff J
    Allerg Immunol (Leipz); 1984; 30(3):139-45. PubMed ID: 6239525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithymocyte antisera globulin effect on human lymphoid neoplasia.
    Pirofsky B; Beaulieu R; Goldman RD
    Arch Intern Med; 1973 Aug; 132(2):171-4. PubMed ID: 4198179
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of chronic lymphatic leukemia with heterologous antilymphocytic serum. I. Obtaining of heterologous serum against lymphocytes of chronic lymphatic leukemia].
    Jasser S; Pawelski S; Skowrońska H; Tupalska B; Brühlowa A
    Acta Haematol Pol; 1971; 2(1):17-25. PubMed ID: 5170673
    [No Abstract]   [Full Text] [Related]  

  • 7. Obtaining, evaluation and clinical application of antileukemic antilymphocyte globulin (ALLG) in the treatment of chronic lymphatic leukemia.
    Bratkowska-Seniów B; Dziedzic J; Kaniak T; Sobolewska B; Stumpf A; Wahl-Mugeńska M; Gieldanowski J; Lisowski J; Ludwikowska A; Szymaniec S; Teodorczyk J; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1977; 25(3):349-65. PubMed ID: 302112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experiences with heterologous antilymphocyte serums in man].
    Pichlmayr R; Brendel W; Zenker R
    Munch Med Wochenschr; 1968 Apr; 110(15):893-8. PubMed ID: 4892058
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies with heterologous antilymphocytic serum as a therapy for chronic lymphocytic leukemia.
    Tsirimbas AD; Pfisterer H; Hornung B; Thierfelder S; Michlmayr G; Stich W
    Blut; 1969 Oct; 19(7):420-3. PubMed ID: 5260739
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antilymphocyte serum. II].
    Bach JF
    Rev Eur Etud Clin Biol; 1970 Mar; 15(3):258-78. PubMed ID: 4986650
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical use of ALG.
    Brendel W
    Transplant Proc; 1971 Mar; 3(1):280-6. PubMed ID: 5095885
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunodepressive and immunostimulant effectiveness of bovine antilymphocyte gamma globulin for humans].
    Antonenko VT; Timchenko AS
    Fiziol Zh; 1976; 22(5):651-5. PubMed ID: 789121
    [No Abstract]   [Full Text] [Related]  

  • 13. A controlled trial antilymphocyte globulin therapy (ALG) in man.
    Sheil AG; Mears D; Kelly GE; Stewart JH; Johnson JR; Tiller D; Gallery ED; Duggin GG
    Transplant Proc; 1972 Dec; 4(4):501-5. PubMed ID: 4118965
    [No Abstract]   [Full Text] [Related]  

  • 14. [Induction of tolerance of heterologous protein in therapy with antilymphocytic globulin in man].
    Tilz GP
    Med Klin; 1972 Mar; 67(12):410-3. PubMed ID: 4112374
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic effect of heterologous antihuma lymphocyte serum (AHLS) in chronic lympahtic leukemia].
    Tsirimbas AD; Pichlmayr R; Hornung B; Pfisterer H; Thierfelder S; Brendel W; Stich W
    Klin Wochenschr; 1968 Jun; 46(11):583-6. PubMed ID: 5755257
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antilymphocyte immunoglobulin with an associated antibacterial directed effect. II. The use of the preparation in the overall therapy of chronic lympholeukemia].
    Shabalin VN; Abdulkadyrov KM; Serova LD; Smirnova AI; Samuskevich IG
    Zh Mikrobiol Epidemiol Immunobiol; 1979 May; (5):26-30. PubMed ID: 377863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of antilymphocyte globulin in the treatment of rheumatoid arthritis].
    Iannotta F; Fantini F; Colombo B
    Minerva Med; 1974 Jan; 65(5):241-8. PubMed ID: 4856472
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of chronic lymphocytic leukemia.
    Silver RT
    Semin Hematol; 1969 Oct; 6(4):344-56. PubMed ID: 4900651
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic lymphatic leukemia: disorders of lymphocyte kinetics. Pathophysiological aspects and therapeutic consideration].
    Bremer K
    Dtsch Med Wochenschr; 1975 May; 100(22):1250-5. PubMed ID: 1132340
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of chronic lymphocytic leukemia].
    Hoerni B; Simon G
    Bord Med; 1971 May; 4(5):1647-50. PubMed ID: 5569954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.